Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 33-37

  Lee, Jungsul ^a   Choi, Kyungsun ^a   Choi, Chulhee ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Cell signaling; Computational modeling; NF B; Post translational modification; Ubiquitin

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; HUMAN; HUMAN CELL; MODEL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIMULATION; UBIQUITINATION;

COMPUTER SIMULATION; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITINATION;

EID: 72949102216     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.155     Document Type: Article

References (31)

1. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210 (2006) 171-186
2. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
3. Krappmann D., and Scheidereit C. A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways. EMBO Rep. 6 (2005) 321-326
4. Chen F., Bhatia D., Chang Q., and Castranova V. Finding NEMO by K63-linked polyubiquitin chain. Cell Death Differ. 13 (2006) 1835-1838
5. Chen Z.J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7 (2005) 758-765
6. Wu C.J., Conze D.B., Li T., Srinivasula S.M., and Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat. Cell Biol. 8 (2006) 398-406
7. Ea C.K., Deng L., Xia Z.P., Pineda G., and Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22 (2006) 245-257
8. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
9. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., Ma A., Koonin E.V., and Dixit V.M. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430 (2004) 694-699
10. de Vrij F.M., Fischer D.F., van Leeuwen F.W., and Hol E.M. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog. Neurobiol. 74 (2004) 249-270
11. Hol E.M., van Leeuwen F.W., and Fischer D.F. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1. Trends Mol. Med. 11 (2005) 488-495
12. Song S., and Jung Y.K. Alzheimer's disease meets the ubiquitin-proteasome system. Trends Mol. Med. 10 (2004) 565-570
13. Melke P., Jonsson H., Pardali E., ten Dijke P., and Peterson C. A rate equation approach to elucidate the kinetics and robustness of the TGF-beta pathway. Biophys. J. 91 (2006) 4368-4380
14. Krishna S., Jensen M.H., and Sneppen K. Minimal model of spiky oscillations in NF-kappaB signaling. Proc. Natl. Acad. Sci. USA 103 (2006) 10840-10845
15. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
16. Blonska M., You Y., Geleziunas R., and Lin X. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells. Mol. Cell. Biol. 24 (2004) 10757-10765
17. Takaesu G., Surabhi R.M., Park K.J., Ninomiya-Tsuji J., Matsumoto K., and Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J. Mol. Biol. 326 (2003) 105-115
18. Burden R.L., and Faires J.D. Numerical analysis (2001), Brooks/Cole, Australia, Pacific Grove, CA
19. Tanaka K., Ii K., Ichihara A., Waxman L., and Goldberg A.L. A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J. Biol. Chem. 261 (1986) 15197-15203
20. Choi C., Kutsch O., Park J., Zhou T., Seol D.W., and Benveniste E.N. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol. Cell. Biol. 22 (2002) 724-736
21. Choi C., Park J.Y., Lee J., Lim J.H., Shin E.C., Ahn Y.S., Kim C.H., Kim S.J., Kim J.D., Choi I.S., and Choi I.H. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J. Immunol. 162 (1999) 1889-1895
22. Zhang S.Q., Kovalenko A., Cantarella G., and Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12 (2000) 301-311
23. Chou I.C., Martens H., and Voit E.O. Parameter estimation in biochemical systems models with alternating regression. Theor. Biol. Med. Model 3 (2006) 25
24. Moles C.G., Mendes P., and Banga J.R. Parameter estimation in biochemical pathways: a comparison of global optimization methods. Genome. Res. 13 (2003) 2467-2474
25. Rodriguez-Fernandez M., Mendes P., and Banga J.R. A hybrid approach for efficient and robust parameter estimation in biochemical pathways. Biosystems 83 (2006) 248-265
26. Zi Z., Cho K.H., Sung M.H., Xia X., Zheng J., and Sun Z. In silico identification of the key components and steps in IFN-gamma induced JAK-STAT signaling pathway. FEBS. Lett. 579 (2005) 1101-1108
27. Choi K., Lee J., and Choi C. Divergent effect of proteasome inhibition on interleukin-1beta and tumor necrosis factor alpha signaling in human astroglial cells. FEBS. Lett. 581 (2007) 4691-4696
28. Van Tijn P., de Vrij F.M., Schuurman K.G., Dantuma N.P., Fischer D.F., van Leeuwen F.W., and Hol E.M. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease. J. Cell. Sci. 120 (2007) 1615-1623
29. van Leeuwen F.W., Fischer D.F., Benne R., and Hol E.M. Molecular misreading. A new type of transcript mutation in gerontology. Ann. NY Acad. Sci. 908 (2000) 267-281
30. Fratta P., Engel W.K., Van Leeuwen F.W., Hol E.M., Vattemi G., and Askanas V. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers. Neurology 63 (2004) 1114-1117
31. Olive M., van Leeuwen F.W., Janue A., Moreno D., Torrejon-Escribano B., and Ferrer I. Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies. Neuropathol. Appl. Neurobiol. 34 (2008) 76-87